Biotech

Biotech stocks pulled back in last week. Incidentally, some large-cap biotech stocks were hitting new peaks even amid the sectoral downturn. New molecular entity approval hit a new peak at 55 thus far this year, compared to 46 in 2017. With that said, here are some catalytic events that can move...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Dec. 6) Gritstone Oncology Inc (NASDAQ: GRTS) Down In The Dumps (Biotech stocks hitting 52-week lows on Dec. 6) Achaogen Inc (NASDAQ: AKAO) Ardelyx Inc...

Here's a roundup of top developments in the biotech space over the past 48 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Dec. 4) Johnson & Johnson (NYSE: JNJ) Eli Lilly And Co (NYSE: LLY) Gritstone Oncology Inc (NASDAQ: GRTS) Merck & Co., Inc. (NYSE: MRK) Pfizer Inc...

Novelion Therapeutics Inc (NASDAQ: NVLN) shares were rallying Tuesday on news of activist involvement. What Happened Novelion revealed through an amendment to a SEC 13-D filing that biotech-focused venture capital firm Healthcare Value Capital sent a letter to Novelion's board urging the...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Dec. 3) Abbott Laboratories (NYSE: ABT) AEterna Zentaris Inc. (NASDAQ: AEZS) Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) argenx SE – ADR (NASDAQ:...

Global Blood Therapeutics Inc (NASDAQ: GBT) shares are trading at a nearly three-month high, with a FDA event being the catalyst. What Happened Global Blood announced Monday that the FDA has agreed to allow filing for its late-stage sickle cell disease, or SCD, candidate Voxelotor under an...

Penny stock Cytori Therapeutics Inc (NASDAQ: CYTX) is seeing strong buying action on news of a device approval in Japan. What Happened Cytori announced it has received approval for its Cellution Cell Therapy System consumable bundle in Japan as a Class III medical device. The...

The year has been good for pharma and biotech companies, with earnings, drug approvals and M&A fueling strong buying in the space. Another multibillion-dollar deal was announced Monday. What Happened Large-cap biotech GlaxoSmithKline plc (NYSE: GSK) and TESARO Inc (NASDAQ: TSRO) announced a...

Large-cap pharma stocks are seeing some upward momentum and are on track to finish the year with handsome gains. As the year draws to a close, it remains to be seen if these stocks can sustain the ongoing momentum. Biotech stocks staged a good recovery in the week ended Nov. 30, snapping three...

Shares of micro-cap Adial Pharmaceuticals Inc (NASDAQ: ADIL) have skyrocketed 196 percent in the past week on news that the company has established a Scientific Advisory Board (SAB) to explore advancement of the company’s leading drug candidate AD04 for the treatment of alcohol use disorder....

The year is drawing to the close, and biotech stocks have had a fairly good run despite the market-wide downturn in October and Novmeber. New molecular moiety (NME) approvals thus far this year totaled 52, already beating the previous year's number of 46. NMEs are active moieties that...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Nov. 29) Allakos Inc (NASDAQ: ALLK) Emergent Biosolutions Inc (NYSE: EBS) Eli Lilly And Co (NYSE: LLY) Merck & Co., Inc. (NYSE: MRK) Pfizer Inc. (NYSE...

Large-cap pharma stocks have had a decent 2018, with strong earnings momentum primarily responsible for the optimism in the space. Tax cuts enabled companies to augment cash reserves, giving them flexibility to pursue inorganic growth to enrich product pipelines. Here's how large...

Tonix Pharmaceuticals (NASDAQ: TNXP) shares — which began to trade on a split-adjusted basis Wednesday after a decision to enact a 1-for-10 reverse stock split — were seeing strong buying interest Thursday morning. What Happened The biopharma company announced Thursday ahead of...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Nov. 28) Merck & Co., Inc. (NYSE: MRK) Ionis Pharmaceuticals Inc (NASDAQ: IONS) Down In The Dumps (Biotech stocks hitting 52-week lows on Nov. 28)...